Maliar, Amit, Servais, Charlotte, Waks, Tova, Chmielewski, Markus, Lavy, Ron, Altevogt, Peter, Abken, Hinrich and Eshhar, Zelig (2012). Redirected T Cells That Target Pancreatic Adenocarcinoma Antigens Eliminate Tumors and Metastases in Mice. Gastroenterology, 143 (5). S. 1375 - 1390. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. ISSN 1528-0012

Full text not available from this repository.

Abstract

BACKGROUND & AIMS: Pancreatic adenocarcinoma (PAC) is often diagnosed at an advanced and inoperable stage, and standard systemic treatments are generally ineffective. We investigated the effects of adoptive transfer of tumor-specific T cells that express chimeric antibody-based receptors (CAR) to mice with primary and metastatic PAC xenografts. METHODS: Human effector T cells were genetically modified to express CAR against Her2/neu or CD24, a putative PAC stem cell antigen. The antitumor reactivity of the engineered T cells (T-bodies) was evaluated in SCID mice with different PAC xenografts. A total of 1 x 10(7) T-bodies were injected via the tail vein or directly administered to the subcutaneous tumor on 3 or 4 alternating days. Mice were then given twice-daily intraperitoneal injections of interleukin-2 for 10 days. RESULTS: Intratumor injection of human CD24 and Her2/neu-specific T-bodies completely eliminated the tumors from most animals. Intravenous injection of T-bodies reduced tumor size and prolonged survival of mice with orthotopically transplanted tumors; more than 50% of animals appeared to be disease-free more than 2 months later. Additional systemic administration of T-bodies 8 weeks after the initial injection eliminated primary tumors, along with liver and draining lymph node metastases. A single administration of the Her2/neuspecific T-bodies prolonged the survival of mice with tumors in which most of the cells expressed the target antigen. In contrast, the CD24-specific T-bodies prolonged survival of mice in which only a subpopulation of the tumor cells expressed the antigen. CONCLUSIONS: CAR-redirected T cells stop growth and metastasis of PAC xenografts in mice. T-bodies specific to CD24, a putative cancer stem cell antigen, were effective against PAC xenografts that had only a subset of antigen-expressing cells.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Maliar, AmitUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Servais, CharlotteUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Waks, TovaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Chmielewski, MarkusUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lavy, RonUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Altevogt, PeterUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Abken, HinrichUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Eshhar, ZeligUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-479858
DOI: 10.1053/j.gastro.2012.07.017
Journal or Publication Title: Gastroenterology
Volume: 143
Number: 5
Page Range: S. 1375 - 1390
Date: 2012
Publisher: W B SAUNDERS CO-ELSEVIER INC
Place of Publication: PHILADELPHIA
ISSN: 1528-0012
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
ADOPTIVE IMMUNOTHERAPY; RECEPTOR; EXPRESSION; IMMUNOGLOBULIN; LYMPHOCYTES; AFFINITY; DOMAINS; CD24; OVEREXPRESSION; AMPLIFICATIONMultiple languages
Gastroenterology & HepatologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/47985

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item